[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335216-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335216-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","weighted-gene-co-expression-network-analysis-identified-gbp2-connected-to-ppar-activity-and-liver-cancer","Weighted gene co-expression network analysis identified GBP2 connected to PPARα activity and liver cancer","","Weighted gene co-expression network analysis was used to uncover molecular mechanisms linking PPARα activity and liver cancer, focusing on candidate biomarkers. Differentially expressed genes from obese patients’ liver cancer tissue and tissue after WY-14643 treatment were analyzed with DESeq2, followed by WGCNA to derive gene modules showing significant negative correlation with drug treatment. Protein–protein interaction and KEGG enrichment analyses were performed, hub genes were screened, and GBP2 was emphasized for its association with clinical outcomes and HCC progression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/weighted-gene-co-expression-network-analysis-identified-gbp2-connected-to-ppar-activity-and-liver-cancer/335216/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/weighted-gene-co-expression-network-analysis-identified-gbp2-connected-to-ppar-activity-and-liver-cancer/335216.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What computational workflow was used to identify genes connected to PPARα activity in liver cancer?","Question",{"text":63,"@type":64},"DESeq2 was used for differentially expressed gene screening, followed by weighted gene co-expression network analysis (WGCNA) to build gene modules and detect those negatively correlated with WY-14643 treatment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were candidate hub genes identified in the study?",{"text":68,"@type":64},"A protein–protein interaction network was constructed, KEGG enrichment was performed, and hub genes were selected using the cyto-hubba plugin, including GBP2 among the core hubs.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is GBP2 highlighted as a biomarker candidate?",{"text":72,"@type":64},"GBP2 showed a negative relation with PPARα agonist treatments and higher expression was closely associated with HCC progression, suggesting relevance to PPARα activity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335216,1790012792,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":118,"preview_page_count":22,"preview_urls":144},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nWeighted gene co‑expression network analysis identified GBP2 connected to PPARα activity and liver cancer  \nMandana AmeliMojarad1,2, Melika AmeliMojarad1,2 & Xiaonan Cui1*  \nLiver cancer is the fourth leading cause of cancer‑related deaths with a steadily increasing rate worldwide, as a well‑known hallmark of liver cancer, metabolic alterations are related to liposomal changes, a common characteristic of primary liver cancers based on recent lipidomics studies. Peroxisome proliferator‑activated receptor α (PPARα) is a ligand‑activated transcription factor with important lipid homeostasis function, therefore we aimed to understand the molecular mechanismsand pathways that activate PPARα after using PPAR‑α agonist WY‑14643 and identify candidate biomarkers related to PPARα activity and evaluate their effects in liver cancer. The data from differently expressed genes (DEGs) between liver cancer tissue from obese subjects alone and liver tissue after treatment were evaluated by DESeq2 and module genes were analyzed using weighted gene co‑expression network analysis (WGCNA). Final candidate genes were identified by intersecting genes among highly ranked DEGs and the brown module, which demonstrated a significant negative correlation with drug treatments. We conducted a protein–protein interaction network, and KEGG enrichment analysis, and core hub genes (CD40, CXCL9, CXCL10, TNFSF14, GBP2, GBP3, APOL3, CLDN1) were identified using the cyto‑hubba plugin, among them we focused on GBP2 that plays key roles in oncogenesis and evaluate its expressional with clinical outcomes. In conclusion, the WGCNA‑ based co‑expression network identified GBP2 as one of the hub genes with a negative relation with PPARα agonist treatments. higher expression of GBP2 was closely associated with HCC progression. Therefore, GBP2 might be a potential candidate for the study of PPARα activity in HCC.  \nKeywords Liver cancer, GBP2, PPARα, WGCNA  \nBackground  \nThe incidence of hepatocellular carcinoma (HCC) continues to increase globally, and the lack of early detection and treatment causes a significant burden1,2. It is estimated that, by 2025, more than 1 million people will be affected by primary liver cancer annually3. The common risk factors for liver cancer development are viral infections, alcohol abuse, and metabolic diseases3. Dysregulation of metabolic processes in the liver as the central metabolism organ plays an important role in cancer development4. Lipids are involved in diverse biological processes in the body, including cancer cells, which rely on lipid uptake, intracellular lipid pools, or membrane remodeling5,6. More ever-activated lipid metabolic pathways increase cancer cells’ resistance to immunotherapy agents6,7. People with obesity or liver diseases frequently have chronic inflammatory conditions and lipid alterations such as intrahepatic lipid accumulation have a higher risk of being influenced by the development of liver cancers, so targeting lipid metabolism could also be a promising therapeutic approach for cancer therapy to overcome tumor resistance3,8.  \nPPAR α is a nuclear receptor that regulates fatty acid oxidation and inflammation through modulation by ligands, PPARα is the most abundant PPAR isotype which contributes to the liver’s remarkable metabolic flexibility9, 10. Currently, peroxisome proliferator (PP) agents such as WY-14643 also known as pirinixic acid considered a potent PPARα activator that is widely used in experimental studies affecting lipid and lipoprotein metabolism11. PPARα activators can lower plasma triglyceride levels and increase HDL cholesterol, they can  \n1 Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China. 2These authors contributed equally: Mandana AmeliMojarad and Melika AmeliMojarad. *email: [cxn23@sina.com](cxn23@sina.com)  \n[www. nature.com/s","cbCaimFN303maGXv","https://ap.wps.com/l/cbCaimFN303maGXv","pdf",1633235,"English","# Background\n# PPARα and lipid metabolism\n# Materials and methods\n## Data source\n## Differentially expressed gene identification","[{\"question\":\"What computational workflow was used to identify genes connected to PPARα activity in liver cancer?\",\"answer\":\"DESeq2 was used for differentially expressed gene screening, followed by weighted gene co-expression network analysis (WGCNA) to build gene modules and detect those negatively correlated with WY-14643 treatment.\"},{\"question\":\"How were candidate hub genes identified in the study?\",\"answer\":\"A protein–protein interaction network was constructed, KEGG enrichment was performed, and hub genes were selected using the cyto-hubba plugin, including GBP2 among the core hubs.\"},{\"question\":\"Why is GBP2 highlighted as a biomarker candidate?\",\"answer\":\"GBP2 showed a negative relation with PPARα agonist treatments and higher expression was closely associated with HCC progression, suggesting relevance to PPARα activity.\"}]","Weighted gene co-expression network analysis identified GBP2 connected to PPARα activity and liver cancer | PDF",1790010192,[145],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/aacebfdb9b195da38af2b6c207df9f7c.webp",983,1291]